These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2612155)

  • 41. Thyroid hormone 5'-deiodinase activity, nuclear binding, and effects on mitogenesis in UMR-106 osteoblastic osteosarcoma cells.
    LeBron BA; Pekary AE; Mirell C; Hahn TJ; Hershman JM
    J Bone Miner Res; 1989 Apr; 4(2):173-8. PubMed ID: 2728922
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of IGF-I and -II, IGF binding protein-3 (IGFBP-3), and transforming growth factor-beta (TGF-beta) on growth and apoptosis of human osteosarcoma Saos-2/B-10 cells: lack of IGF-independent IGFBP-3 effects.
    Schmid C; Ghirlanda-Keller C; Zapf J
    Eur J Endocrinol; 2001 Aug; 145(2):213-21. PubMed ID: 11454519
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Estrogen enhances differentiation of osteoblasts in mouse bone marrow culture.
    Qu Q; Perälä-Heape M; Kapanen A; Dahllund J; Salo J; Väänänen HK; Härkönen P
    Bone; 1998 Mar; 22(3):201-9. PubMed ID: 9514212
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Estrogen mitogenic action. ii. negative regulation of the steroid hormone-responsive growth of cell lines derived from human and rodent target tissue tumors and conceptual implications.
    Sirbasku DA; Moreno-Cuevas JE
    In Vitro Cell Dev Biol Anim; 2000; 36(7):428-46. PubMed ID: 11039494
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Estradiol-17 beta, insulin-like growth factor-I, and luteinizing hormone inhibit secretion of transforming growth factor beta by rat ovarian theca-interstitial cells.
    Magoffin DA; Hubert-Leslie D; Zachow RJ
    Biol Reprod; 1995 Sep; 53(3):627-35. PubMed ID: 7578687
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Human osteoblasts' proliferative responses to strain and 17beta-estradiol are mediated by the estrogen receptor and the receptor for insulin-like growth factor I.
    Cheng MZ; Rawlinson SC; Pitsillides AA; Zaman G; Mohan S; Baylink DJ; Lanyon LE
    J Bone Miner Res; 2002 Apr; 17(4):593-602. PubMed ID: 11924572
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transforming growth factor-beta modulates the expression of osteoblast and chondroblast phenotypes in vitro.
    Rosen DM; Stempien SA; Thompson AY; Seyedin SM
    J Cell Physiol; 1988 Mar; 134(3):337-46. PubMed ID: 3162457
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Estrogen modulates parathyroid hormone-induced fibronectin production in human and rat osteoblast-like cells.
    Eielson C; Kaplan D; Mitnick MA; Paliwal I; Insogna K
    Endocrinology; 1994 Oct; 135(4):1639-44. PubMed ID: 7925127
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interactions between FSH, estradiol-17 beta and transforming growth factor-beta regulate growth and differentiation in the rat gonad.
    Dorrington JH; Bendell JJ; Khan SA
    J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):441-7. PubMed ID: 8476758
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cyclic stretch increases alkaline phosphatase activity of osteoblast-like cells: a role for prostaglandin E2.
    Nishioka S; Fukuda K; Tanaka S
    Bone Miner; 1993 May; 21(2):141-50. PubMed ID: 8358251
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increased resistance to transforming growth factor beta accompanies neoplastic progression of rat tracheal epithelial cells.
    Hubbs AF; Hahn FF; Thomassen DG
    Carcinogenesis; 1989 Sep; 10(9):1599-605. PubMed ID: 2766454
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 17beta-Estradiol overcomes human myeloma RPMI8226 cell suppression of growth, ALP activity, and mineralization in rat osteoblasts and improves RANKL/OPG balance in vitro.
    Li Q; Yu K; Tian X; Kong F; You Y; Chen Z; Zou P
    Leuk Res; 2009 Sep; 33(9):1266-71. PubMed ID: 19167063
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bovine colostric transforming growth factor-beta-like peptide that induces growth inhibition and changes in morphology of human osteogenic sarcoma cells (MG-63).
    Tokuyama H; Tokuyama Y
    Cell Biol Int Rep; 1989 Mar; 13(3):251-8. PubMed ID: 2706687
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differential effects of transforming growth factor-beta and epidermal growth factor on the cell cycle of cultured rabbit articular chondrocytes.
    Vivien D; Galéra P; Lebrun E; Loyau G; Pujol JP
    J Cell Physiol; 1990 Jun; 143(3):534-45. PubMed ID: 2358472
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A phorbol ester induces secretion of alkaline phosphatase activity in human osteosarcoma cells.
    Ringbom-Anderson T; Akerman KE
    Calcif Tissue Int; 1992 Jun; 50(6):533-40. PubMed ID: 1525710
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of transforming growth factor beta on proliferation of L6 and embryonic porcine myogenic cells.
    Pampusch MS; Hembree JR; Hathaway MR; Dayton WR
    J Cell Physiol; 1990 Jun; 143(3):524-8. PubMed ID: 2358471
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Growth modulatory effects of a liver-derived growth inhibitor, transforming growth factor beta 1, and recombinant tumor necrosis factor alpha, in normal and neoplastic cells.
    Chapekar MS; Huggett AC; Thorgeirsson SS
    Exp Cell Res; 1989 Nov; 185(1):247-57. PubMed ID: 2806409
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 17 beta-oestradiol enhances the stimulatory effect of 1,25-dihydroxyvitamin D3 on alkaline phosphatase activity in human osteosarcoma SaOS-2 cells in a differentiation-dependent manner.
    Rao LG; Wylie JN; Kung Sutherland MS; Murray TM
    J Endocrinol; 1996 Jan; 148(1):181-7. PubMed ID: 8568466
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differential effects of transforming growth factor beta on human prostate cancer cells in vitro.
    Wilding G; Zugmeier G; Knabbe C; Flanders K; Gelmann E
    Mol Cell Endocrinol; 1989 Mar; 62(1):79-87. PubMed ID: 2545487
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Response of normal female human osteoblasts (NHOst) to 17beta-estradiol is modulated by implant surface morphology.
    Lohmann CH; Tandy EM; Sylvia VL; Hell-Vocke AK; Cochran DL; Dean DD; Boyan BD; Schwartz Z
    J Biomed Mater Res; 2002 Nov; 62(2):204-13. PubMed ID: 12209940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.